"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

ERIS Lifesciences Ltd
Industry : Pharmaceuticals - Indian - Formulations	Chairman : Amit Indubhushan Bakshi
Home : Indian Private	Book Value: 203.3941378
BSE Code : 540596	Market Cap: 22667.85
NSE Code : ERIS	P / E : 80.43

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Type	2Qtr	1Qtr	4Qtr	3Qtr
Net Sales	637.58	567.90	395.71	390.00
Other Income	23.59	22.68	16.75	7.79
Total Income	674.09	601.32	421.52	407.52
Total Expenditure	353.62	362.32	283.80	300.16
Operating Profit	320.47	239.00	137.72	107.36
Interest	46.50	45.14	53.16	54.65
Gross Profit	273.97	193.86	84.56	52.71
Depreciation	39.30	37.60	43.38	46.68
Tax	40.91	27.17	8.51	0.00
Deferred Tax	44.19	29.10	2.20	4.25
Reported Profit After Tax	149.57	99.99	30.47	1.78

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView